# Novavax Inc: Form SCHEDULE 13D/A, filed Apr 8, 2026

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-08
- Accepted by EDGAR: Apr 8, 2026, 06:00 ET
- Period: not reported
- Accession: 0001398344-26-006235
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000139834426006235/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000139834426006235/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000139834426006235/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001398344-26-006235. Last ingested by Listed: Nov 10, 2026, 17:20 ET. No prices; not investment advice.